Related Experiment Video
Updated: Sep 26, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Exploratory Biomarker-Defined Phenotypic Heterogeneity Beyond a Single Physiological Reserve Construct
Muneera O AlTaweel1,2,3, Aftab Ahmed Jalbani1, Fahad Memon1
1Department of Cardiac Sciences, King Abdulaziz Hospital, MNGHA, King Abdullah Military City, Al-Mubarraz 36248, Al-Ahsa, Saudi Arabia.
Abstract:
Background: Patient heterogeneity in routine biomarkers is often collapsed into a single physiological reserve score, but whether that one-dimensional representation holds across acute and chronic settings-or whether it obscures biomarker-defined subgroups relevant to individualized care-is unclear. Methods: We harmonized routine biomarkers (BMI, blood pressure, eGFR, LDL, total cholesterol, and HbA1c) across two cohorts from the same health system: an acute cardiorenal syndrome cohort and a chronic outpatient cohort treated with dapagliflozin and/or semaglutide, excluding 15 patients common to both. We tested whether these biomarkers supported a one-factor structure via exploratory factor analysis, then a categorical alternative via Gaussian mixture modeling, assessed six-month class persistence in the chronic cohort, and applied the derived classes to the acute cohort for descriptive independent cohort application. Results: A one-factor representation was not supported (KMO = 0.485; covariance concentrated in two definitionally related variable pairs). Gaussian mixture modeling favored a two-class solution, distinguished mainly by LDL, total cholesterol, HbA1c, and diastolic blood pressure. Class assignment showed moderate six-month agreement (κ = 0.46) in a subgroup enriched for closer monitoring. In the acute cohort, class structure was not clearly associated with age, BNP, ejection fraction, length of stay, CKD stage, HF phenotype, NYHA class, or comorbidities; associations with outcomes were descriptive, not causal. Conclusions: Rather than reducing to a single reserve score, these biomarkers were better described by an exploratory two-class, biomarker-defined phenotype structure that captured observable patient heterogeneity, showed moderate short-term persistence, and was not clearly related to acute illness severity. These findings are specific to the biomarkers and cohorts studied and should not be generalized without independent replication.
Related Concept Videos
Heritability
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets